Morphinan-3-ol, 17-(2-propenyl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), mixt. with ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate hydrochloride (8056-47-1)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate (1:1) (salt), mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with (R*,S*)-(+-)-alpha-(1-aminoethyl)benzenemethanol and N-(4-hydroxyphenyl)acetamide
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
- 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (R)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
- 17-[(2E)-3-methylpent-2-en-4-yn-1-yl]morphinan-3-ol 2,3-dihydroxybutanedioate (salt)
- Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
- 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
- Morphinan,3-methoxy-17-methyl-,hydrobromide,(9R,13R,14R)-,mixt. with rel-(RS)-R-[(1R)-1-aminoethyl]- benzenemethanol hydrochloride,ç-(4-chlorophenyl)-N,N-dimethyl-2- pyridinepropanamine (2Z)-2-butenedioate (1:1) and N-(4-hydroxyphenyl)acetamide
- 4(1H)-Quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-, (R-(R*,R*))-2,3-dihydroxybutanedioate
- Vitamin B12, mixt. with (R-(R*,R*))-2,3-dihydroxybutanedioic acid, 5-hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride, iron dextran and tylosin (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
- Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
- Benzenemethanol, a-[1-[methyl(3-phenyl-2-propenyl)amino]ethyl]-,hydrochloride, [R-(R*,S*)]- (9CI)
- 17-[2-(4-methoxyphenyl)ethyl]morphinan-3-ol 2,3-dihydroxybutanedioate (salt)
- 17-[(2E)-3-methylpent-2-en-1-yl]morphinan-3-ol 2,3-dihydroxybutanedioate (salt)
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,mixt. with 4-hydroxy-R,R,4-trimethylcyclohexanemethanol monohydrate and sodium hydrogen carbonate
- Butanedioic acid,2-cyano-3-methyl-, 4-ethyl 1-(2-propenyl) ester, [S-(R*,R*)]- (9CI)
- Butanedioic acid,2-cyano-3-methyl-, 4-ethyl 1-(2-propenyl) ester, [R-(R*,S*)]- (9CI)
- 17-[(3-hydroxycyclobutyl)methyl]morphinan-3,14-diol 2,3-dihydroxybutanedioate (2:1) (salt)
- Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(phenylmethyl)-,(5'R)-,(2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt),mixt. with 1-[(4-chlorophenyl)phenylmethyl]- 4-[(3-methylphenyl)methyl]piperazine dihydrochloride and 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione
- Pyridinium,3-[[(dimethylamino)carbonyl]oxy]- 1-methyl-,mixt. with R-cyclohexyl-R-phenyl-1-piperidinepropanol and 2-(diethylamino)ethyl R-hydroxy-R-phenylbenzeneacetate
